pharmaceutical composition for subcutaneous administration, method of treating a patient suffering from trauma or blood clotting disease, kit of parts, and dosage form of a pharmaceutical composition
The present invention provides a pharmaceutical composition for subcutaneous administration comprising a blood factor and a colloidal particle comprising about 0.5 to 20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer, wherein the blood factor is not encapsulated in said colloidal particle.